Purchase this article with an account.
C.E. Jahn, H. Strotmann; Investigation of the Safe Use in Humans of an Intraocular Lens With Reversibly Adjustable Optical Power: *Acri.Tec AR–1 PC/IOL . Invest. Ophthalmol. Vis. Sci. 2005;46(13):804.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Purpose: To examine the safety of a newly developed intraocular lens with reversibly adjustable optical power (*Acri.Tec AR–1 intraocular lens (PC/IOL)) after implantation into adult human eyes. Methods: Implantation of the *Acri.Tec AR–1 PC/IOL into 15 human eyes of 15 patients undergoing cataract surgery by phacoemulsification and as control the implantation of a conventional PC/IOL into the second eye of 12 patients. Follow–up after implantation was 2 – 8 months. Results: : Implantation was possible without any problem. Eyes healed normally. No difference between eyes containing the *Acri.Tec AR–1 PC/IOL and eyes containing conventional PC/ IOLs could be detected with respect to visual acuity, stabilization of refractive error, signs of inflammatory reaction, slit–lamp microscopic aspect of the eye, and intraocular pressure. Conclusions: These data suggest that the *Acri.Tec AR–1 PC/IOL can be safely implanted into the capsular bag of adult human eyes. Further exploration of the potential usefullness of this type of reversibly adjustable PC/IOL is reasonable.
This PDF is available to Subscribers Only